The surge in MRNA stock comes after some SEC filings show that company insiders bought shares worth $6 million.

There is no better period, given the volatility in the markets today, to rotate assets into dividend stocks, said Steven ...

Drugs in late-stage development may mean competition on price for two Pfizer medications that, by some accounts, are the most expensive cardiac medications in history.

Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...

Moderna (MRNA) stock is climbing 8% after the drug maker won a key court case and its CEO bought shares on the open market.